Skip to content

Tenofovir Alafenamide

Published: July 26, 2026Updated: August 26, 2026

Vemlidy (tenofovir alafenamide) is a prescription antiviral medication used to treat chronic hepatitis B virus (HBV) infection in adults and pediatric patients. It is a nucleoside analog reverse transcriptase inhibitor that works by suppressing the replication of the hepatitis B virus in the body. Vemlidy is often considered a preferred option due to its improved safety profile for kidney and bone health compared to older formulations.

Quick summary

Vemlidy is an antiviral medication used to treat chronic hepatitis B infection in adults and children.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

RxNorm
1858262
Generic
Vemlidy
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Vemlidy is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients aged 12 years and older with compensated liver disease.

Vemlidy contains tenofovir alafenamide, a prodrug that is converted intracellularly to tenofovir diphosphate. This active metabolite inhibits HBV reverse transcriptase, blocking viral replication by incorporating into the viral DNA and causing chain termination.

Vemlidy may cause serious side effects including lactic acidosis, severe hepatomegaly with steatosis, and acute exacerbation of hepatitis after discontinuation. It is not a cure for HBV and does not prevent transmission to others. Patients should have their kidney function monitored during treatment. Common side effects may include headache, stomach pain, fatigue, and nausea.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy